(VIANEWS) – MACOM Technology Solutions Holdings (MTSI), Novo Nordisk A/S (NVO), Fulton Financial Corporation (FULT) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. MACOM Technology Solutions Holdings (MTSI)
32.1% sales growth and 6.58% return on equity
MACOM Technology Solutions Holdings, Inc., together with its subsidiaries, designs and manufactures analog semiconductor solutions for use in wireless and wireline applications across the radio frequency (RF), microwave, millimeter wave, and lightwave spectrum in the United States, China, the Asia Pacific, and internationally. The company offers a portfolio of standard and custom devices, including integrated circuits, multi-chip modules, diodes, amplifiers, switches and switch limiters, passive and active components, and subsystems. Its semiconductor products are electronic components that are incorporated in electronic systems, such as wireless basestations, high capacity optical networks, radar, and medical systems and test and measurement. The company serves various markets comprising telecommunication that includes carrier infrastructure, which comprise long-haul/metro, 5G, and fiber-to-the-X/passive optical network; data centres; and industrial and defense, including military and commercial radar, RF jammers, electronic countermeasures, and communication data links, as well as multi-market applications, such as industrial, medical, test and measurement, and scientific applications. It sells its products through direct sales force, applications engineering staff, independent sales representatives, resellers, and distributors. The company was founded in 1950 and is headquartered in Lowell, Massachusetts.
Earnings Per Share
As for profitability, MACOM Technology Solutions Holdings has a trailing twelve months EPS of $0.89.
PE Ratio
MACOM Technology Solutions Holdings has a trailing twelve months price to earnings ratio of 111.9. Meaning, the purchaser of the share is investing $111.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.58%.
Moving Average
MACOM Technology Solutions Holdings’s worth is under its 50-day moving average of $100.27 and way above its 200-day moving average of $87.92.
Volume
Today’s last reported volume for MACOM Technology Solutions Holdings is 410584 which is 25.59% below its average volume of 551834.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7%, now sitting on 637.28M for the twelve trailing months.
2. Novo Nordisk A/S (NVO)
27.6% sales growth and 99.87% return on equity
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Earnings Per Share
As for profitability, Novo Nordisk A/S has a trailing twelve months EPS of $2.71.
PE Ratio
Novo Nordisk A/S has a trailing twelve months price to earnings ratio of 45.94. Meaning, the purchaser of the share is investing $45.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 99.87%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Mar 22, 2024, the estimated forward annual dividend rate is 1.37 and the estimated forward annual dividend yield is 1.01%.
3. Fulton Financial Corporation (FULT)
22.7% sales growth and 10.34% return on equity
Fulton Financial Corporation operates as a financial holding company that provides consumer and commercial banking products and services. It accepts various checking accounts and savings deposit products, certificates of deposit, and individual retirement accounts. The company also offers secured consumer loans, including home equity loans and lines of credit, automobile loans, personal lines of credit, and checking account overdraft protection; construction and jumbo residential mortgage loans; and commercial lending products comprising commercial real estate, commercial and industrial, and construction loans, as well as equipment lease financing loans. In addition, it provides letters of credit, cash management services, and traditional deposit products; and wealth management services, including investment management, trust, brokerage, insurance, and investment advisory services. Further, the company owns passive investments, as well as trust preferred securities; and sells various life insurance products. It provides its products and services through traditional financial center banking, as well as through a network of automated teller machines, telephone banking, mobile banking, and online banking. The company operated branches in Pennsylvania, Maryland, Delaware, New Jersey, and Virginia. Fulton Financial Corporation was incorporated in 1882 and is headquartered in Lancaster, Pennsylvania.
Earnings Per Share
As for profitability, Fulton Financial Corporation has a trailing twelve months EPS of $1.61.
PE Ratio
Fulton Financial Corporation has a trailing twelve months price to earnings ratio of 10.25. Meaning, the purchaser of the share is investing $10.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.34%.
Previous days news about Fulton Financial Corporation(FULT)
- According to Zacks on Friday, 7 June, "The banks are Old National Bancorp (ONB Quick QuoteONB – Free Report) , Fulton Financial Corporation (FULT Quick QuoteFULT – Free Report) , F.N.B. Corporation (FNB Quick QuoteFNB – Free Report) , WaFd, Inc. (WAFD Quick QuoteWAFD – Free Report) , First Merchants Corp. and Peapack-Gladstone Financial Corp."
4. Astrazeneca (AZN)
13.9% sales growth and 17.29% return on equity
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Earnings Per Share
As for profitability, Astrazeneca has a trailing twelve months EPS of $1.9.
PE Ratio
Astrazeneca has a trailing twelve months price to earnings ratio of 36.28. Meaning, the purchaser of the share is investing $36.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.29%.
Moving Average
Astrazeneca’s worth is under its 50-day moving average of $72.65 and higher than its 200-day moving average of $67.71.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 47.61B for the twelve trailing months.
5. Universal Technical Institute (UTI)
13.1% sales growth and 10.75% return on equity
Universal Technical Institute, Inc. provides transportation and technical training programs in the United States. It offers certificate, diploma, or degree programs under various brands, such as Universal Technical Institute, Motorcycle Mechanics Institute and Marine Mechanics Institute, NASCAR Technical Institute, and MIAT College of Technology. The company also provides manufacturer specific advanced training programs, including student paid electives at its campuses; and manufacturer or dealer sponsored training at various campuses and dedicated training centers, as well as offers programs for welding and CNC machining. As of September 30, 2022, it operated 16 campuses. Universal Technical Institute, Inc. was founded in 1965 and is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, Universal Technical Institute has a trailing twelve months EPS of $0.37.
PE Ratio
Universal Technical Institute has a trailing twelve months price to earnings ratio of 42.73. Meaning, the purchaser of the share is investing $42.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.75%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.4%, now sitting on 682.45M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 260% and 210%, respectively.
Yearly Top and Bottom Value
Universal Technical Institute’s stock is valued at $15.81 at 20:22 EST, under its 52-week high of $17.09 and way higher than its 52-week low of $6.26.
6. Iron Mountain Incorporated (IRM)
9.2% sales growth and 47.37% return on equity
Iron Mountain Incorporated (NYSE: IRM), founded in 1951, is the global leader for storage and information management services. Trusted by more than 225,000 organizations around the world, and with a real estate network of more than 90 million square feet across more than 1,480 facilities in approximately 50 countries, Iron Mountain stores and protects billions of valued assets, including critical business information, highly sensitive data, and cultural and historical artifacts. Providing solutions that include secure records storage, information management, digital transformation, secure destruction, as well as data centers, cloud services and art storage and logistics, Iron Mountain helps customers lower cost and risk, comply with regulations, recover from disaster, and enable a more digital way of working.
Earnings Per Share
As for profitability, Iron Mountain Incorporated has a trailing twelve months EPS of $0.65.
PE Ratio
Iron Mountain Incorporated has a trailing twelve months price to earnings ratio of 122.31. Meaning, the purchaser of the share is investing $122.31 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 47.37%.
7. Copa Holdings, S.A. Copa Holdings, S.A. (CPA)
8.5% sales growth and 29.96% return on equity
Copa Holdings, S.A., through its subsidiaries, provides airline passenger and cargo services. The company offers approximately 104 daily scheduled flights to 54 destinations in 25 countries in North, Central, and South America, as well as the Caribbean from its Panama City hub. As of December 31, 2020, it operated a fleet of 77 aircraft comprising 70 Boeing 737-Next Generation aircraft and 7 Boeing 737 MAX 9 aircraft. Copa Holdings, S.A. was founded in 1947 and is based in Panama City, Panama.
Earnings Per Share
As for profitability, Copa Holdings, S.A. Copa Holdings, S.A. has a trailing twelve months EPS of $13.9.
PE Ratio
Copa Holdings, S.A. Copa Holdings, S.A. has a trailing twelve months price to earnings ratio of 7.24. Meaning, the purchaser of the share is investing $7.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.96%.
Yearly Top and Bottom Value
Copa Holdings, S.A. Copa Holdings, S.A.’s stock is valued at $100.65 at 20:22 EST, way below its 52-week high of $121.20 and way higher than its 52-week low of $78.12.
